Beyond Bone Density: How Fracture Risk Is Changing Osteoporosis Management - Quiz - MDSpire

Beyond Bone Density: How Fracture Risk Is Changing Osteoporosis Management

As osteoporosis treatment continues to evolve, clinicians are moving beyond bone mineral density scores alone and placing greater emphasis on fracture risk when making therapeutic decisions

  • By

  • July 8, 2026

  • 7 min

Share

Original Source(s)

Beyond Bone Density: How Fracture Risk Is Changing Osteoporosis Management

  • by

  • July 8, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

GLP-1 RAs May Ease Psoriasis, PsA Data Limited

Published evidence linked liraglutide and semaglutide to improvements in psoriasis severity, inflammatory markers, and metabolic outcomes, while evidence in psoriatic arthritis remained sparse.